You need JavaScript to view this

Clinical features and applications of thallium-201. With reference to scintigraphy

Abstract

Thallium-201 is not only used widely in myocardial imaging but also has a great potential in other various nuclear medicine imaging studies. This paper presents clinical features and applications of thallium-201, focusing on clinical trials with thallium-201 at the Shinshu University School of Medicine. Thallium-201 myocardial scintigraphy offers information on (1) ventricular position and morphology, (2) hypertrophy or dilatation of the left ventricle, (3) hypertrophy or dilatation of the right ventricle, (4) site and extent of myocardial ischemia and infarct, (5) myocardial blood flow, (6) pulmonary congestion or interstitial pulmonary edema, and (7) pericardial effusion. It can be used in the following evaluation or diagnosis: (1) acute or old myocardial infarction, (2) angina pectoris, (3) treatment strategy or prognosis of ischemic heart disease, (4) treatment strategy or observation of bypass graft or drug therapy, (5) hypertrophic or dilated idiopathic cardiomyopathy, (6) myocardial lesions induced by sarcoidosis, collagen disease, and neuro-muscular disease, (7) ventricular hypertrophy and pulmonary edema, and (9) pericarditis, pericardial effusion, and systolic pericarditis associated with underlying disease. The significance of tumor, liver, bone marrow scintigraphies is also referred to. (Namekawa, K) 69 refs.
Authors:
Publication Date:
Dec 01, 1988
Product Type:
Journal Article
Reference Number:
JPN-89-009536; EDB-89-103301
Resource Relation:
Journal Name: Shinshu Igaku Zasshi; (Japan); Journal Volume: 36:6
Subject:
62 RADIOLOGY AND NUCLEAR MEDICINE; THALLIUM 201; SCINTISCANNING; BLOOD FLOW; BONE MARROW; BRONCHITIS; CARCINOMAS; HYPERTENSION; LUNGS; MYELOID LEUKEMIA; MYOCARDIAL INFARCTION; MYOCARDIUM; PATIENTS; THYROID; UPTAKE; ANIMAL TISSUES; BETA DECAY RADIOISOTOPES; BODY; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; COUNTING TECHNIQUES; DAYS LIVING RADIOISOTOPES; DIAGNOSTIC TECHNIQUES; DISEASES; ELECTRON CAPTURE RADIOISOTOPES; ENDOCRINE GLANDS; GLANDS; HEART; HEAVY NUCLEI; HEMATOPOIETIC SYSTEM; HEMIC DISEASES; IMMUNE SYSTEM DISEASES; ISOMERIC TRANSITION ISOTOPES; ISOTOPES; LEUKEMIA; MUSCLES; NEOPLASMS; NUCLEI; ODD-EVEN NUCLEI; ORGANS; RADIOISOTOPE SCANNING; RADIOISOTOPES; RESPIRATORY SYSTEM; RESPIRATORY SYSTEM DISEASES; SECONDS LIVING RADIOISOTOPES; SYMPTOMS; THALLIUM ISOTOPES; TISSUES; VASCULAR DISEASES; 550601* - Medicine- Unsealed Radionuclides in Diagnostics
OSTI ID:
6072952
Research Organizations:
Shinshu Univ., Matsumoto, Nagano (Japan). Faculty of Medicine
Country of Origin:
Japan
Language:
Japanese
Other Identifying Numbers:
Journal ID: CODEN: SIZAA
Submitting Site:
JPN
Size:
Pages: 765-780
Announcement Date:
Apr 01, 1989

Citation Formats

Fujii, Tadashige. Clinical features and applications of thallium-201. With reference to scintigraphy. Japan: N. p., 1988. Web.
Fujii, Tadashige. Clinical features and applications of thallium-201. With reference to scintigraphy. Japan.
Fujii, Tadashige. 1988. "Clinical features and applications of thallium-201. With reference to scintigraphy." Japan.
@misc{etde_6072952,
title = {Clinical features and applications of thallium-201. With reference to scintigraphy}
author = {Fujii, Tadashige}
abstractNote = {Thallium-201 is not only used widely in myocardial imaging but also has a great potential in other various nuclear medicine imaging studies. This paper presents clinical features and applications of thallium-201, focusing on clinical trials with thallium-201 at the Shinshu University School of Medicine. Thallium-201 myocardial scintigraphy offers information on (1) ventricular position and morphology, (2) hypertrophy or dilatation of the left ventricle, (3) hypertrophy or dilatation of the right ventricle, (4) site and extent of myocardial ischemia and infarct, (5) myocardial blood flow, (6) pulmonary congestion or interstitial pulmonary edema, and (7) pericardial effusion. It can be used in the following evaluation or diagnosis: (1) acute or old myocardial infarction, (2) angina pectoris, (3) treatment strategy or prognosis of ischemic heart disease, (4) treatment strategy or observation of bypass graft or drug therapy, (5) hypertrophic or dilated idiopathic cardiomyopathy, (6) myocardial lesions induced by sarcoidosis, collagen disease, and neuro-muscular disease, (7) ventricular hypertrophy and pulmonary edema, and (9) pericarditis, pericardial effusion, and systolic pericarditis associated with underlying disease. The significance of tumor, liver, bone marrow scintigraphies is also referred to. (Namekawa, K) 69 refs.}
journal = []
volume = {36:6}
journal type = {AC}
place = {Japan}
year = {1988}
month = {Dec}
}